Browse by Clinical Topic:


Featured CME/CE Content:
 
neuroscienceCME Editors' Picks:



Live Q&A: Cardiology: Real-World Tactics to Address Health Inequities

Premiere Date: Thursday, February 2, 2023

This activity will offer CE credit for:

  1. Medicine (accme)
  2. Nursing (ANCC)
  3. Pharmacy (acpe)
  4. PA (aapa)
  5. Other


All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Creditâ„¢

Credit Expiration Date:
Monday, February 2, 2026

Faculty


Monica E. Peek, MD, MPH, MScMonica E. Peek, MD, MPH, MSc (Moderator)
(she/her/hers)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, IL

Utibe R. Essien, MD, MPH Utibe R. Essien, MD, MPH  
(he/him/his)
Assistant Professor of Medicine
Assistant Vice Chair, Equity Diversity and Inclusion
Department of Medicine
David Geffen School of Medicine at University of California, Los Angeles
Los Angeles, CA

Statement of Need

More than 12 million people in the United States will have AF by 2030, quintupling their risk for severe ischemic strokes. While the introduction of direct oral anticoagulants (DOACs) has enhanced stroke prophylaxis in AF, these medications are not equitably offered to all individuals, for a variety of reasons – both explicit and implicit. In this CME Outfitters BriefCase activity, an expert faculty followed the journey of a 48-year-old Black female with AF to illuminate disparities in the quality of care she was offered.

This live Q&A session with the original BriefCase faculty is your opportunity to ask questions about how implicit bias, social determinants of health, shared decision making, and health literacy can impact the care of your own patients with AF, and what you can do to ensure appropriate anticoagulation to prevent ischemic stroke is available to all who need it. To view the full activity ahead of this live Q&A, click here.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Identify the impact of health inequities in cardiology patients with atrial fibrillation.
  • Individualize a holistic treatment plan for cardiology care to improve patient outcomes.

Financial Support

Supported by an educational grant from Johnson & Johnson.

Target Audience

Physicians, PAs, NPs, nurses, and pharmacists specializing in cardiology, surgery, primary care, or emergency medicine.

Credit Information

Specific CE Credit information is not available at this time. Please check again soon!

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Peek reports the following financial relationships:

Consultant: Pfizer Inc.

Dr. Bond reports no financial relationships to disclose.

Dr. Essien reports the following financial relationships:

Grants: Department of Veterans Affairs Health Services Research and Development Division

The following peer reviewer and CME Outfitters staff have no financial relationships:
  • Jeffrey Helfand, DO (peer reviewer)
  • Meghann Taft-Lockard (planning committee)
  • Thomas Mitchell (planning committee)
  • Warren Beckman (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)


  • Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

    Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

    BCQ-074-020223-57

    Home      |      Register/Log In      |      Activities      |      Communities of Practice      |      About      |      Download